Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs
The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to their use in diverse applications. One promising strategy is to deliver IgGs using a bispecific BBB shuttle, which involves fusing an IgG to a second affinity ligand that engages a cerebrovascular endotheli...
Saved in:
| Published in | Cell chemical biology Vol. 31; no. 2; pp. 361 - 372.e8 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Ltd
15.02.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to their use in diverse applications. One promising strategy is to deliver IgGs using a bispecific BBB shuttle, which involves fusing an IgG to a second affinity ligand that engages a cerebrovascular endothelial target and facilitates transport across the BBB. Nearly all prior efforts have focused on shuttles that target transferrin receptor (TfR-1) despite inherent delivery and safety challenges. Here, we report bispecific antibody shuttles that engage CD98hc, the heavy chain of the large neutral amino acid transporter (LAT1), and efficiently transport IgGs into the brain. Notably, CD98hc shuttles lead to much longer-lived brain retention of IgGs than TfR-1 shuttles while enabling more specific targeting due to limited CD98hc engagement in the brain parenchyma, which we demonstrate for IgGs that either agonize a neuronal receptor (TrkB) or target other endogenous cell-surface proteins on neurons and astrocytes.
[Display omitted]
•Bispecific antibody shuttles targeting CD98hc result in extended brain retention•CD98hc shuttles delivering untargeted IgGs remain localized to blood vessels•CD98hc shuttles targeting neurons and astrocytes display cell-type specificity•TrkB/CD98hc agonist shuttles demonstrate extended TrkB receptor activation
Although the blood-brain barrier largely inhibits brain entry of biologics, Pornnoppadol et al. demonstrated a bispecific antibody shuttle targeting CD98hc for transport of IgGs into the brain and showed that it displays much longer-lived brain retention than transferrin receptor shuttles while selectively targeting different brain cell types. |
|---|---|
| AbstractList | The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to their use in diverse applications. One promising strategy is to deliver IgGs using a bispecific BBB shuttle, which involves fusing an IgG to a second affinity ligand that engages a cerebrovascular endothelial target and facilitates transport across the BBB. Nearly all prior efforts have focused on shuttles that target transferrin receptor (TfR-1) despite inherent delivery and safety challenges. Here, we report bispecific antibody shuttles that engage CD98hc, the heavy chain of the large neutral amino acid transporter (LAT1), and efficiently transport IgGs into the brain. Notably, CD98hc shuttles lead to much longer-lived brain retention of IgGs than TfR-1 shuttles while enabling more specific targeting due to limited CD98hc engagement in the brain parenchyma, which we demonstrate for IgGs that either agonize a neuronal receptor (TrkB) or target other endogenous cell-surface proteins on neurons and astrocytes.
[Display omitted]
•Bispecific antibody shuttles targeting CD98hc result in extended brain retention•CD98hc shuttles delivering untargeted IgGs remain localized to blood vessels•CD98hc shuttles targeting neurons and astrocytes display cell-type specificity•TrkB/CD98hc agonist shuttles demonstrate extended TrkB receptor activation
Although the blood-brain barrier largely inhibits brain entry of biologics, Pornnoppadol et al. demonstrated a bispecific antibody shuttle targeting CD98hc for transport of IgGs into the brain and showed that it displays much longer-lived brain retention than transferrin receptor shuttles while selectively targeting different brain cell types. The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to their use in diverse applications. One promising strategy is to deliver IgGs using a bispecific BBB shuttle, which involves fusing an IgG to a second affinity ligand that engages a cerebrovascular endothelial target and facilitates transport across the BBB. Nearly all prior efforts have focused on shuttles that target transferrin receptor (TfR-1) despite inherent delivery and safety challenges. Here, we report bispecific antibody shuttles that engage CD98hc, the heavy chain of the large neutral amino acid transporter (LAT1), and efficiently transport IgGs into the brain. Notably, CD98hc shuttles lead to much longer-lived brain retention of IgGs than TfR-1 shuttles while enabling more specific targeting due to limited CD98hc engagement in the brain parenchyma, which we demonstrate for IgGs that either agonize a neuronal receptor (TrkB) or target other endogenous cell-surface proteins on neurons and astrocytes. |
| Author | Zhang, Boya Pornnoppadol, Ghasidit Bond, Layne G. Tessier, Peter M. Kuo, Yun-Huai Greineder, Colin F. Zupancic, Jennifer M. Lucas, Michael J. |
| Author_xml | – sequence: 1 givenname: Ghasidit surname: Pornnoppadol fullname: Pornnoppadol, Ghasidit organization: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 2 givenname: Layne G. surname: Bond fullname: Bond, Layne G. organization: Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 3 givenname: Michael J. surname: Lucas fullname: Lucas, Michael J. organization: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 4 givenname: Jennifer M. surname: Zupancic fullname: Zupancic, Jennifer M. organization: Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 5 givenname: Yun-Huai surname: Kuo fullname: Kuo, Yun-Huai organization: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 6 givenname: Boya surname: Zhang fullname: Zhang, Boya organization: Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 7 givenname: Colin F. surname: Greineder fullname: Greineder, Colin F. email: coling@umich.edu organization: Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA – sequence: 8 givenname: Peter M. orcidid: 0000-0002-3220-007X surname: Tessier fullname: Tessier, Peter M. email: ptessier@umich.edu organization: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37890480$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkNFOwjAUhhujEURegfQFNtu167Y7FRVJSLzR62ZrT6FkbKQtJLy9XRBuvTo9J-dr-38P6LbrO0BoRklKCRVP21RtYNfYvk0zkrGUVCkh5Q0aZzynScV5eXs952KEpt5vCYkkKygr7tGIFWVFeEnGCF6t34Oyxipcd8E2vT5hvzmE0ILHoXZrCLZb4_lbVW4U3oG2dQAMJgIWuhAhjdu-WyetPYLGjatthzUMnTvh3uDleuEf0Z2pWw_TvzpBPx_v3_PPZPW1WM5fVoliogwJ1QaKrNIacsEULwg3mjZC8zgnJmOGKZMXgtZxoLgWwA3RwAUxlalUIdgEifO9yvXeOzBy7-yudidJiRzUya28qJODOkkqGdVFcHYG94cmZrxiF1Fx4fm8APH7RwtO-iG_ij4cqCB1b_974xeEsIbA |
| CitedBy_id | crossref_primary_10_1080_17425247_2023_2286371 crossref_primary_10_1093_jbmr_zjae050 crossref_primary_10_3389_fncel_2023_1327621 crossref_primary_10_1039_D3NA01125A |
| Cites_doi | 10.1096/fj.201902515RR 10.1126/scitranslmed.aay1163 10.3233/JAD-140741 10.7150/thno.17155 10.1016/j.nurt.2009.01.017 10.1002/bit.22135 10.1227/00006123-199510000-00018 10.1124/dmd.109.031534 10.1016/j.medj.2022.09.007 10.1002/jsscb.1981.380150404 10.1038/nature19323 10.1126/scitranslmed.3005338 10.1371/journal.pone.0080110 10.1096/fj.202001787R 10.1007/s004180050266 10.1016/j.molmed.2012.09.001 10.3389/fphys.2020.00973 10.1126/scitranslmed.3009835 10.3390/pharmaceutics14071335 10.1074/jbc.270.25.14913 10.1111/j.1471-4159.1992.tb08880.x 10.1056/NEJMoa2203395 10.1021/bc060349x 10.1038/tp.2016.186 10.1523/JNEUROSCI.17-10-03623.1997 10.1080/19420862.2022.2146629 10.1016/j.xpro.2021.100499 10.1080/19420862.2018.1564510 10.1097/00004647-200011000-00005 10.1186/s13195-018-0377-8 10.2217/cns.15.8 10.1007/978-1-62703-444-9_17 10.3389/fncel.2019.00004 10.1016/j.neuron.2013.10.061 10.7150/thno.44165 10.1016/0304-3940(85)90428-8 10.1111/jnc.14482 10.7326/0003-4819-77-2-295 10.1080/19420862.2016.1268307 10.1016/0006-8993(95)00596-I 10.1016/j.celrep.2017.12.019 10.1080/19420862.2018.1465159 10.1073/pnas.91.11.5104 10.1038/s41467-022-31457-3 10.1007/s13311-022-01248-1 10.1093/protein/9.7.617 10.1038/s41586-019-1011-z 10.1073/pnas.1713969114 10.1126/scitranslmed.3002230 10.1038/nature22044 10.1056/NEJMoa2202867 10.1080/19420862.2015.1117720 10.1016/j.ymthe.2018.02.032 10.1146/annurev-neuro-070918-050501 10.1111/j.1471-4159.1990.tb04886.x 10.1016/j.omtm.2020.08.014 10.1016/j.addr.2021.113834 10.1074/jbc.M116.767749 10.1016/j.neuron.2015.11.024 10.1073/pnas.91.12.5705 10.1038/nbt0798-677 10.1056/NEJM197512112932401 10.1016/j.hest.2020.04.003 10.1021/acs.molpharmaceut.7b00200 10.1073/pnas.88.11.4771 10.1021/acs.molpharmaceut.7b00937 10.1038/s41594-019-0237-7 10.1093/protein/gzw040 10.1056/NEJMe2207681 10.1186/1471-2377-9-S1-S3 10.1101/cshperspect.a020412 10.1046/j.1471-4159.1998.70020883.x 10.1097/j.pain.0000000000000810 10.1371/journal.pone.0252558 10.1016/j.neuron.2017.04.010 10.1126/scitranslmed.aay1359 10.1111/j.1749-6632.1992.tb24578.x 10.1038/nrneurol.2017.148 10.1523/JNEUROSCI.1118-06.2006 10.1084/jem.20131660 10.1016/j.drudis.2006.10.013 10.3171/2014.9.FOCUS14516 |
| ContentType | Journal Article |
| Copyright | 2023 Elsevier Ltd Copyright © 2023 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2023 Elsevier Ltd – notice: Copyright © 2023 Elsevier Ltd. All rights reserved. |
| DBID | NPM AAYXX CITATION |
| DOI | 10.1016/j.chembiol.2023.09.008 |
| DatabaseName | PubMed CrossRef |
| DatabaseTitle | PubMed CrossRef |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 2451-9448 2451-9456 |
| EndPage | 372.e8 |
| ExternalDocumentID | 10_1016_j_chembiol_2023_09_008 37890480 S2451945623003276 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K08 HL130430 – fundername: NIA NIH HHS grantid: F32 AG079576 – fundername: NIA NIH HHS grantid: RF1 AG059723 – fundername: NINDS NIH HHS grantid: T32 NS007222 – fundername: NIGMS NIH HHS grantid: R35 GM136300 – fundername: NIA NIH HHS grantid: R01 AG080016 |
| GroupedDBID | 0R~ 457 53G AACTN AAEDT AAEDW AAIAV AAKRW AAVLU AAXUO ABJNI ABMAC ACGFS ACIUM ADBBV AFTJW AITUG AKAPO AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FCP FDB FIRID HH5 JIG KOO M41 O9- OK1 RCE RIG ROL NPM 0SF 186 AALRI AAMRU AAYXX ABVKL ADVLN CITATION EJD NCXOZ SSZ |
| ID | FETCH-LOGICAL-c368t-1dfe729dde563c4704fd1b6d4dfe0f23f3cf5761a4dfc4d6e4f0de460f9f9c763 |
| ISSN | 2451-9456 |
| IngestDate | Thu Sep 26 17:57:40 EDT 2024 Sat Nov 02 12:29:28 EDT 2024 Sat May 25 15:41:39 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | 4F2 blood-brain barrier TrkB BBB BDNF neuron transferrin receptor SLC3A2 neurotrophin astrocyte |
| Language | English |
| License | Copyright © 2023 Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c368t-1dfe729dde563c4704fd1b6d4dfe0f23f3cf5761a4dfc4d6e4f0de460f9f9c763 |
| ORCID | 0000-0002-3220-007X |
| PMID | 37890480 |
| ParticipantIDs | crossref_primary_10_1016_j_chembiol_2023_09_008 pubmed_primary_37890480 elsevier_sciencedirect_doi_10_1016_j_chembiol_2023_09_008 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-15 |
| PublicationDateYYYYMMDD | 2024-02-15 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cell chemical biology |
| PublicationTitleAlternate | Cell Chem Biol |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Pardridge, Buciak, Friden (bib11) 1991; 259 Hasegawa, Cheng, Hayashi, Takemoto, Kim-Mitsuyama (bib80) 2020; 1 Makowski, Kinnunen, Huang, Wu, Smith, Wang, Desai, Streu, Zhang, Zupancic (bib86) 2022; 13 Bujotzek, Lipsmeier, Harris, Benz, Kuglstatter, Georges (bib81) 2016; 8 Poduslo, Curran, Berg (bib3) 1994; 91 Merchant, Zhu, Yuan, Goddard, Adams, Presta, Carter (bib22) 1998; 16 Thom, Burrell, Haqqani, Yogi, Lessard, Brunette, Delaney, Baumann, Callaghan, Rodrigo (bib29) 2018; 15 Kim, Cho, Nelson, Zipfel, Han (bib68) 2014; 9 Rinaldi, Wood (bib64) 2018; 14 Yu, Zhang, Kenrick, Hoyte, Luk, Lu, Atwal, Elliott, Prabhu, Watts, Dennis (bib4) 2011; 3 Sevigny, Chiao, Bussière, Weinreb, Williams, Maier, Dunstan, Salloway, Chen, Ling (bib53) 2016; 537 Tsukahara, Takeda, Shimohama, Ohara, Hashimoto (bib73) 1995; 37 Bennett E.M., Higginson-Scott N., Tchistiakova L., Marquette K. A., Paulsen J. E., Gimeno R. E. Bispecific Antibodies. US 2020/0123260 A1, 2020. Yoshimoto, Lin, Collier, Frim, Breakefield, Bohn (bib71) 1995; 691 Niewoehner, Bohrmann, Collin, Urich, Sade, Maier, Rueger, Stracke, Lau, Tissot (bib8) 2014; 81 Lo, Kim, Tong, Bainbridge, Vernes, Zhang, Lin, Chung, Dennis, Zuchero (bib25) 2017; 292 Couch, Yu, Zhang, Tarrant, Fuji, Meilandt, Solanoy, Tong, Hoyte, Luk (bib13) 2013; 5 Jin (bib79) 2020; 9 Zaragozá (bib40) 2020; 11 Chang, Knox, Chang, Derbedrossian, Vasilevko, Cribbs, Boado, Pardridge, Sumbria (bib45) 2017; 14 Syvänen, Hultqvist, Gustavsson, Gumucio, Laudon, Söderberg, Ingelsson, Lannfelt, Sehlin (bib50) 2018; 10 Alcántara, Frisén, del Río, Soriano, Barbacid, Silos-Santiago (bib77) 1997; 17 Ullman, Arguello, Getz, Bhalla, Mahon, Wang, Giese, Bedard, Kim, Blumenfeld (bib9) 2020; 12 Yasutomo K. Novel anti-cd98 antibody and use thereof. US 2013/0052197 A1, 2013. Kang, Wu, Liu, Edgington-Mitchell, Ye (bib75) 2022; 19 Ghiaseddin, Peters (bib55) 2015; 4 Lund, Chang, Hankin, Lagenaur (bib31) 1985; 61 Rahal (bib57) 1972; 77 Wang, Yao, Xu, Hao, Zhang, Liu, Huang, Guo, Lu (bib66) 2020; 10 Pardridge (bib6) 2003; 6 Hultqvist, Syvänen, Fang, Lannfelt, Sehlin (bib28) 2017; 7 Zuchero, Chen, Bien-Ly, Bumbaca, Tong, Gao, Zhang, Hoyte, Luk, Huntley (bib17) 2016; 89 Schlothauer, Herter, Koller, Grau-Richards, Steinhart, Spick, Kubbies, Klein, Umaña, Mössner (bib26) 2016; 29 Scoles, Meera, Schneider, Paul, Dansithong, Figueroa, Hung, Rigo, Bennett, Otis, Pulst (bib63) 2017; 544 Friden, Walus, Musso, Taylor, Malfroy, Starzyk (bib10) 1991; 88 Lee, Wiriyasermkul, Jin, Quan, Ohgaki, Okuda, Kusakizako, Nishizawa, Oda, Ishitani (bib15) 2019; 26 Kiseleva, Glassman, LeForte, Walsh, Villa, Shuvaev, Myerson, Aprelev, Marcos-Contreras, Muzykantov, Greineder (bib87) 2020; 34 Yan, Zhao, Lei, Zhou (bib16) 2019; 568 Whone (bib37) 2022; 387 Jiao, Shen, Zhu, Bu, Liu, Liu, Yao, Zhang, Zhou, Walker (bib74) 2016; 6 Duelli, Enerson, Gerhart, Drewes (bib39) 2000; 20 Wang, Matise (bib88) 2013; 1018 Boado, Zhang, Wang, Pardridge (bib24) 2009; 102 Do, Capdevila, Pradier, Blanchard, Lopez-Grancha, Schussler, Steinmetz, Beninga, Boulay, Dugay (bib43) 2020; 19 Kaiser, McGee (bib58) 1975; 293 Sánchez del Pino, Peterson, Hawkins (bib38) 1995; 270 Brinkmann, Kontermann (bib42) 2017; 9 Pornnoppadol, Zhang, Desai, Berardi, Remmer, Tessier, Greineder (bib33) 2021; 16 Stocki, Szary, Rasmussen, Demydchuk, Northall, Logan, Gauhar, Thei, Moos, Walsh, Rutkowski (bib14) 2021; 35 Huwyler, Pardridge (bib41) 1998; 70 Webster, Hatcher, Burrell, Thom, Thornton, Gurrell, Chessell (bib47) 2017; 158 Bennett, Krainer, Cleveland (bib60) 2019; 42 Kang, Zhang, Liu, Manfredsson, Benskey, Cao, Xu, Sun, Ye (bib76) 2017; 114 Qian, Zhang, Tan, Wood, Gill, Cho (bib83) 2006; 26 Lagenaur, Schachner (bib32) 1981; 15 Greineder, Chacko, Zaytsev, Zern, Carnemolla, Hood, Han, Ding, Esmon, Muzykantov (bib84) 2013; 8 Sonoda, Morimoto, Yoden, Koshimura, Kinoshita, Golovina, Takagi, Yamamoto, Minami, Mizoguchi (bib46) 2018; 26 Castro, Aghi (bib56) 2014; 37 Schoch, Miller (bib65) 2017; 94 Bien-Ly, Yu, Bumbaca, Elstrott, Boswell, Zhang, Luk, Lu, Dennis, Weimer (bib7) 2014; 211 Makowski, Chen, Lambert, Bennett, Eschmann, Zhang, Zupancic, Desai, Smith, Lou (bib85) 2022; 14 Gupta, Andresen, Manan, Langer (bib61) 2021; 178 Spina, Hyman, Squinto, Lindsay (bib72) 1992; 648 Lang, Siderowf, Macklin, Poewe, Brooks, Fernandez, Rascol, Giladi, Stocchi, Tanner (bib35) 2022; 387 Kissel, Hamm, Schulz, Vecchi, Garlanda, Engelhardt (bib82) 1998; 110 Boado, Zhang, Zhang, Xia, Pardridge (bib44) 2007; 18 Pardridge (bib5) 2007; 12 Haqqani, Thom, Burrell, Delaney, Brunette, Baumann, Sodja, Jezierski, Webster, Stanimirovic (bib19) 2018; 146 Daneman, Prat (bib1) 2015; 7 Zhou, Boado, Lu, Hui, Pardridge (bib48) 2010; 38 Rogawski (bib59) 2009; 6 Clarke, Stocki, Sinclair, Gauhar, Fletcher, Krawczun-Rygmaczewska, Duty, Walsh, Doherty, Rutkowski (bib67) 2022; 14 Montroull, Danelon, Cragnolini, Mascó (bib78) 2019; 13 Edavettal, Cejudo-Martin, Dasgupta, Yang, Buschman, Domingo, Van Kolen, Jaiprasat, Gordon, Schutsky (bib18) 2022; 3 Pagano, Taylor, Anzures-Cabrera, Marchesi, Simuni, Marek, Postuma, Pavese, Stocchi, Azulay (bib36) 2022; 387 Southwell, Skotte, Bennett, Hayden (bib62) 2012; 18 Fra-Bido, Walker, Innocentin, Linterman (bib89) 2021; 2 Neiveyans, Melhem, Arnoult, Bourquard, Jarlier, Busson, Laroche, Cerutti, Pugnière, Ternant (bib27) 2019; 11 Yu, Atwal, Zhang, Tong, Wildsmith, Tan, Bien-Ly, Hersom, Maloney, Meilandt (bib49) 2014; 6 Spina, Squinto, Miller, Lindsay, Hyman (bib69) 1992; 59 Banks (bib2) 2009; 9 Karaoglu Hanzatian, Schwartz, Gizatullin, Erickson, Deng, Villanueva, Stedman, Harris, Ghayur, Goodearl (bib51) 2018; 10 Triguero, Buciak, Pardridge (bib30) 1990; 54 Ridgway, Presta, Carter (bib23) 1996; 9 Kariolis, Wells, Getz, Kwan, Mahon, Tong, Kim, Srivastava, Bedard, Henne (bib20) 2020; 12 Tucker, Möller, Tegerstedt, Lord, Laudon, Sjödahl, Söderberg, Spens, Sahlin, Waara (bib54) 2015; 43 Weber, Bohrmann, Niewoehner, Fischer, Rueger, Tiefenthaler, Moelleken, Bujotzek, Brady, Singer (bib52) 2018; 22 Lee, Engelhardt, Lesley, Bickel, Pardridge (bib12) 2000; 292 Frim, Uhler, Galpern, Beal, Breakefield, Isacson (bib70) 1994; 91 37162883 - bioRxiv. 2023 Apr 29 37923842 - Nat Rev Drug Discov. 2023 Dec;22(12):952 Yan (10.1016/j.chembiol.2023.09.008_bib16) 2019; 568 Kiseleva (10.1016/j.chembiol.2023.09.008_bib87) 2020; 34 Edavettal (10.1016/j.chembiol.2023.09.008_bib18) 2022; 3 Lagenaur (10.1016/j.chembiol.2023.09.008_bib32) 1981; 15 Syvänen (10.1016/j.chembiol.2023.09.008_bib50) 2018; 10 Tucker (10.1016/j.chembiol.2023.09.008_bib54) 2015; 43 Wang (10.1016/j.chembiol.2023.09.008_bib66) 2020; 10 Sevigny (10.1016/j.chembiol.2023.09.008_bib53) 2016; 537 Ullman (10.1016/j.chembiol.2023.09.008_bib9) 2020; 12 Banks (10.1016/j.chembiol.2023.09.008_bib2) 2009; 9 10.1016/j.chembiol.2023.09.008_bib21 Do (10.1016/j.chembiol.2023.09.008_bib43) 2020; 19 Zuchero (10.1016/j.chembiol.2023.09.008_bib17) 2016; 89 Triguero (10.1016/j.chembiol.2023.09.008_bib30) 1990; 54 Gupta (10.1016/j.chembiol.2023.09.008_bib61) 2021; 178 Greineder (10.1016/j.chembiol.2023.09.008_bib84) 2013; 8 Pardridge (10.1016/j.chembiol.2023.09.008_bib6) 2003; 6 Poduslo (10.1016/j.chembiol.2023.09.008_bib3) 1994; 91 Lang (10.1016/j.chembiol.2023.09.008_bib35) 2022; 387 Zaragozá (10.1016/j.chembiol.2023.09.008_bib40) 2020; 11 Southwell (10.1016/j.chembiol.2023.09.008_bib62) 2012; 18 Scoles (10.1016/j.chembiol.2023.09.008_bib63) 2017; 544 Niewoehner (10.1016/j.chembiol.2023.09.008_bib8) 2014; 81 Duelli (10.1016/j.chembiol.2023.09.008_bib39) 2000; 20 Fra-Bido (10.1016/j.chembiol.2023.09.008_bib89) 2021; 2 Pardridge (10.1016/j.chembiol.2023.09.008_bib5) 2007; 12 Daneman (10.1016/j.chembiol.2023.09.008_bib1) 2015; 7 Hasegawa (10.1016/j.chembiol.2023.09.008_bib80) 2020; 1 Clarke (10.1016/j.chembiol.2023.09.008_bib67) 2022; 14 Bien-Ly (10.1016/j.chembiol.2023.09.008_bib7) 2014; 211 Neiveyans (10.1016/j.chembiol.2023.09.008_bib27) 2019; 11 Bujotzek (10.1016/j.chembiol.2023.09.008_bib81) 2016; 8 Ridgway (10.1016/j.chembiol.2023.09.008_bib23) 1996; 9 10.1016/j.chembiol.2023.09.008_bib34 Spina (10.1016/j.chembiol.2023.09.008_bib69) 1992; 59 Yu (10.1016/j.chembiol.2023.09.008_bib49) 2014; 6 Rinaldi (10.1016/j.chembiol.2023.09.008_bib64) 2018; 14 Pornnoppadol (10.1016/j.chembiol.2023.09.008_bib33) 2021; 16 Rogawski (10.1016/j.chembiol.2023.09.008_bib59) 2009; 6 Jin (10.1016/j.chembiol.2023.09.008_bib79) 2020; 9 Frim (10.1016/j.chembiol.2023.09.008_bib70) 1994; 91 Makowski (10.1016/j.chembiol.2023.09.008_bib85) 2022; 14 Karaoglu Hanzatian (10.1016/j.chembiol.2023.09.008_bib51) 2018; 10 Tsukahara (10.1016/j.chembiol.2023.09.008_bib73) 1995; 37 Kim (10.1016/j.chembiol.2023.09.008_bib68) 2014; 9 Boado (10.1016/j.chembiol.2023.09.008_bib44) 2007; 18 Kaiser (10.1016/j.chembiol.2023.09.008_bib58) 1975; 293 Kang (10.1016/j.chembiol.2023.09.008_bib75) 2022; 19 Zhou (10.1016/j.chembiol.2023.09.008_bib48) 2010; 38 Whone (10.1016/j.chembiol.2023.09.008_bib37) 2022; 387 Montroull (10.1016/j.chembiol.2023.09.008_bib78) 2019; 13 Lund (10.1016/j.chembiol.2023.09.008_bib31) 1985; 61 Makowski (10.1016/j.chembiol.2023.09.008_bib86) 2022; 13 Thom (10.1016/j.chembiol.2023.09.008_bib29) 2018; 15 Huwyler (10.1016/j.chembiol.2023.09.008_bib41) 1998; 70 Hultqvist (10.1016/j.chembiol.2023.09.008_bib28) 2017; 7 Alcántara (10.1016/j.chembiol.2023.09.008_bib77) 1997; 17 Sánchez del Pino (10.1016/j.chembiol.2023.09.008_bib38) 1995; 270 Kang (10.1016/j.chembiol.2023.09.008_bib76) 2017; 114 Wang (10.1016/j.chembiol.2023.09.008_bib88) 2013; 1018 Boado (10.1016/j.chembiol.2023.09.008_bib24) 2009; 102 Sonoda (10.1016/j.chembiol.2023.09.008_bib46) 2018; 26 Rahal (10.1016/j.chembiol.2023.09.008_bib57) 1972; 77 Webster (10.1016/j.chembiol.2023.09.008_bib47) 2017; 158 Lee (10.1016/j.chembiol.2023.09.008_bib15) 2019; 26 Pagano (10.1016/j.chembiol.2023.09.008_bib36) 2022; 387 Ghiaseddin (10.1016/j.chembiol.2023.09.008_bib55) 2015; 4 Pardridge (10.1016/j.chembiol.2023.09.008_bib11) 1991; 259 Bennett (10.1016/j.chembiol.2023.09.008_bib60) 2019; 42 Kissel (10.1016/j.chembiol.2023.09.008_bib82) 1998; 110 Friden (10.1016/j.chembiol.2023.09.008_bib10) 1991; 88 Lo (10.1016/j.chembiol.2023.09.008_bib25) 2017; 292 Merchant (10.1016/j.chembiol.2023.09.008_bib22) 1998; 16 Kariolis (10.1016/j.chembiol.2023.09.008_bib20) 2020; 12 Chang (10.1016/j.chembiol.2023.09.008_bib45) 2017; 14 Weber (10.1016/j.chembiol.2023.09.008_bib52) 2018; 22 Yu (10.1016/j.chembiol.2023.09.008_bib4) 2011; 3 Schlothauer (10.1016/j.chembiol.2023.09.008_bib26) 2016; 29 Brinkmann (10.1016/j.chembiol.2023.09.008_bib42) 2017; 9 Haqqani (10.1016/j.chembiol.2023.09.008_bib19) 2018; 146 Lee (10.1016/j.chembiol.2023.09.008_bib12) 2000; 292 Stocki (10.1016/j.chembiol.2023.09.008_bib14) 2021; 35 Yoshimoto (10.1016/j.chembiol.2023.09.008_bib71) 1995; 691 Schoch (10.1016/j.chembiol.2023.09.008_bib65) 2017; 94 Couch (10.1016/j.chembiol.2023.09.008_bib13) 2013; 5 Castro (10.1016/j.chembiol.2023.09.008_bib56) 2014; 37 Spina (10.1016/j.chembiol.2023.09.008_bib72) 1992; 648 Jiao (10.1016/j.chembiol.2023.09.008_bib74) 2016; 6 Qian (10.1016/j.chembiol.2023.09.008_bib83) 2006; 26 |
| References_xml | – volume: 54 start-page: 1882 year: 1990 end-page: 1888 ident: bib30 article-title: Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins publication-title: J. Neurochem. contributor: fullname: Pardridge – volume: 14 start-page: 1335 year: 2022 ident: bib67 article-title: A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s Disease publication-title: Pharmaceutics contributor: fullname: Rutkowski – volume: 26 start-page: 9394 year: 2006 end-page: 9403 ident: bib83 article-title: Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities publication-title: J. Neurosci. contributor: fullname: Cho – volume: 12 start-page: 54 year: 2007 end-page: 61 ident: bib5 article-title: Blood-brain barrier delivery publication-title: Drug Discov. Today contributor: fullname: Pardridge – volume: 11 start-page: 593 year: 2019 end-page: 605 ident: bib27 article-title: A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions publication-title: mAbs contributor: fullname: Ternant – volume: 61 start-page: 221 year: 1985 end-page: 226 ident: bib31 article-title: Use of a species-specific antibody for demonstrating mouse neurons transplanted to rat brains publication-title: Neurosci. Lett. contributor: fullname: Lagenaur – volume: 1018 start-page: 175 year: 2013 end-page: 188 ident: bib88 article-title: Immunofluorescence staining with frozen mouse or chick embryonic tissue sections publication-title: Methods Mol. Biol. contributor: fullname: Matise – volume: 94 start-page: 1056 year: 2017 end-page: 1070 ident: bib65 article-title: Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases publication-title: Neuron contributor: fullname: Miller – volume: 9 start-page: S3 year: 2009 ident: bib2 article-title: Characteristics of compounds that cross the blood-brain barrier publication-title: BMC Neurol. contributor: fullname: Banks – volume: 292 start-page: 3900 year: 2017 end-page: 3908 ident: bib25 article-title: Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice publication-title: J. Biol. Chem. contributor: fullname: Zuchero – volume: 3 start-page: 860 year: 2022 end-page: 882.e15 ident: bib18 article-title: Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis publication-title: Med. contributor: fullname: Schutsky – volume: 26 start-page: 1366 year: 2018 end-page: 1374 ident: bib46 article-title: A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II publication-title: Mol. Ther. contributor: fullname: Mizoguchi – volume: 6 start-page: 261ra154 year: 2014 ident: bib49 article-title: Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates publication-title: Sci. Transl. Med. contributor: fullname: Meilandt – volume: 34 start-page: 11577 year: 2020 end-page: 11593 ident: bib87 article-title: Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery publication-title: FASEB J. contributor: fullname: Greineder – volume: 146 start-page: 735 year: 2018 end-page: 752 ident: bib19 article-title: Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier publication-title: J. Neurochem. contributor: fullname: Stanimirovic – volume: 12 year: 2020 ident: bib9 article-title: Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice publication-title: Sci. Transl. Med. contributor: fullname: Blumenfeld – volume: 91 start-page: 5705 year: 1994 end-page: 5709 ident: bib3 article-title: Macromolecular permeability across the blood-nerve and blood-brain barriers publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Berg – volume: 6 start-page: 683 year: 2003 end-page: 691 ident: bib6 article-title: Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain publication-title: Curr. Opin. Drug Discov. Dev contributor: fullname: Pardridge – volume: 211 start-page: 233 year: 2014 end-page: 244 ident: bib7 article-title: Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants publication-title: J. Exp. Med. contributor: fullname: Weimer – volume: 537 start-page: 50 year: 2016 end-page: 56 ident: bib53 article-title: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease publication-title: Nature contributor: fullname: Ling – volume: 14 start-page: 9 year: 2018 end-page: 21 ident: bib64 article-title: Antisense oligonucleotides: the next frontier for treatment of neurological disorders publication-title: Nat. Rev. Neurol. contributor: fullname: Wood – volume: 544 start-page: 362 year: 2017 end-page: 366 ident: bib63 article-title: Antisense oligonucleotide therapy for spinocerebellar ataxia type 2 publication-title: Nature contributor: fullname: Pulst – volume: 22 start-page: 149 year: 2018 end-page: 162 ident: bib52 article-title: Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode publication-title: Cell Rep. contributor: fullname: Singer – volume: 4 start-page: 157 year: 2015 end-page: 169 ident: bib55 article-title: Use of bevacizumab in recurrent glioblastoma publication-title: CNS Oncol. contributor: fullname: Peters – volume: 2 year: 2021 ident: bib89 article-title: Optimized immunofluorescence staining protocol for imaging germinal centers in secondary lymphoid tissues of vaccinated mice publication-title: STAR Protoc. contributor: fullname: Linterman – volume: 43 start-page: 575 year: 2015 end-page: 588 ident: bib54 article-title: The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice publication-title: J. Alzheimers Dis. contributor: fullname: Waara – volume: 6 year: 2016 ident: bib74 article-title: Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease publication-title: Transl. Psychiatry contributor: fullname: Walker – volume: 17 start-page: 3623 year: 1997 end-page: 3633 ident: bib77 article-title: TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death publication-title: J. Neurosci. contributor: fullname: Silos-Santiago – volume: 9 start-page: 182 year: 2017 end-page: 212 ident: bib42 article-title: The making of bispecific antibodies publication-title: mAbs contributor: fullname: Kontermann – volume: 16 year: 2021 ident: bib33 article-title: A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain publication-title: PLoS One contributor: fullname: Greineder – volume: 178 year: 2021 ident: bib61 article-title: Nucleic acid delivery for therapeutic applications publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Langer – volume: 114 start-page: 10773 year: 2017 end-page: 10778 ident: bib76 article-title: TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Ye – volume: 110 start-page: 63 year: 1998 end-page: 72 ident: bib82 article-title: Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody publication-title: Histochem. Cell Biol. contributor: fullname: Engelhardt – volume: 158 start-page: 660 year: 2017 end-page: 668 ident: bib47 article-title: Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-Transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity publication-title: Pain contributor: fullname: Chessell – volume: 10 start-page: 765 year: 2018 end-page: 777 ident: bib51 article-title: Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration publication-title: mAbs contributor: fullname: Goodearl – volume: 568 start-page: 127 year: 2019 end-page: 130 ident: bib16 article-title: Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex publication-title: Nature contributor: fullname: Zhou – volume: 102 start-page: 1251 year: 2009 end-page: 1258 ident: bib24 article-title: Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse publication-title: Biotechnol. Bioeng. contributor: fullname: Pardridge – volume: 292 start-page: 1048 year: 2000 end-page: 1052 ident: bib12 article-title: Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse publication-title: J. Pharmacol. Exp. Therapeut. contributor: fullname: Pardridge – volume: 15 start-page: 1420 year: 2018 end-page: 1431 ident: bib29 article-title: Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26 publication-title: Mol. Pharm. contributor: fullname: Rodrigo – volume: 13 start-page: 3788 year: 2022 ident: bib86 article-title: Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space publication-title: Nat. Commun. contributor: fullname: Zupancic – volume: 10 start-page: 49 year: 2018 ident: bib50 article-title: Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody publication-title: Alzheimer's Res. Ther. contributor: fullname: Sehlin – volume: 387 start-page: 408 year: 2022 end-page: 420 ident: bib35 article-title: Trial of Cinpanemab in Early Parkinson's Disease publication-title: N. Engl. J. Med. contributor: fullname: Tanner – volume: 11 start-page: 973 year: 2020 ident: bib40 article-title: Transport of Amino Acids Across the Blood-Brain Barrier publication-title: Front. Physiol. contributor: fullname: Zaragozá – volume: 7 start-page: a020412 year: 2015 ident: bib1 article-title: The blood-brain barrier publication-title: Cold Spring Harbor Perspect. Biol. contributor: fullname: Prat – volume: 15 start-page: 335 year: 1981 end-page: 346 ident: bib32 article-title: Monoclonal antibody (M2) to glial and neuronal cell surfaces publication-title: J. Supramol. Struct. Cell. Biochem. contributor: fullname: Schachner – volume: 14 start-page: 2146629 year: 2022 ident: bib85 article-title: Reduction of therapeutic antibody self-association using yeast-display selections and machine learning publication-title: mAbs contributor: fullname: Lou – volume: 89 start-page: 70 year: 2016 end-page: 82 ident: bib17 article-title: Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies publication-title: Neuron contributor: fullname: Huntley – volume: 387 start-page: 421 year: 2022 end-page: 432 ident: bib36 article-title: Trial of Prasinezumab in Early-Stage Parkinson's Disease publication-title: N. Engl. J. Med. contributor: fullname: Azulay – volume: 38 start-page: 566 year: 2010 end-page: 572 ident: bib48 article-title: Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse publication-title: Drug Metab. Dispos. contributor: fullname: Pardridge – volume: 8 year: 2013 ident: bib84 article-title: Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor publication-title: PLoS One contributor: fullname: Muzykantov – volume: 26 start-page: 510 year: 2019 end-page: 517 ident: bib15 article-title: Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc publication-title: Nat. Struct. Mol. Biol. contributor: fullname: Ishitani – volume: 70 start-page: 883 year: 1998 end-page: 886 ident: bib41 article-title: Examination of blood-brain barrier transferrin receptor by confocal fluorescent microscopy of unfixed isolated rat brain capillaries publication-title: J. Neurochem. contributor: fullname: Pardridge – volume: 77 start-page: 295 year: 1972 end-page: 302 ident: bib57 article-title: Treatment of gram-negative bacillary meningitis in adults publication-title: Ann. Intern. Med. contributor: fullname: Rahal – volume: 1 start-page: 124 year: 2020 end-page: 132 ident: bib80 article-title: Anti-apoptotic effects of BDNF-TrkB signaling in the treatment of hemorrhagic stroke publication-title: Brain Hemorrhages contributor: fullname: Kim-Mitsuyama – volume: 19 start-page: 58 year: 2020 end-page: 77 ident: bib43 article-title: Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model publication-title: Mol. Ther. Methods Clin. Dev. contributor: fullname: Dugay – volume: 387 start-page: 466 year: 2022 end-page: 467 ident: bib37 article-title: Monoclonal Antibody Therapy in Parkinson's Disease - The End? publication-title: N. Engl. J. Med. contributor: fullname: Whone – volume: 59 start-page: 99 year: 1992 end-page: 106 ident: bib69 article-title: Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system publication-title: J. Neurochem. contributor: fullname: Hyman – volume: 9 year: 2020 ident: bib79 article-title: Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease publication-title: J. Clin. Med. contributor: fullname: Jin – volume: 13 start-page: 4 year: 2019 ident: bib78 article-title: Loss of TrkB Signaling Due to Status Epilepticus Induces a proBDNF-Dependent Cell Death publication-title: Front. Cell. Neurosci. contributor: fullname: Mascó – volume: 270 start-page: 14913 year: 1995 end-page: 14918 ident: bib38 article-title: Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier publication-title: J. Biol. Chem. contributor: fullname: Hawkins – volume: 3 start-page: 84ra44 year: 2011 ident: bib4 article-title: Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target publication-title: Sci. Transl. Med. contributor: fullname: Dennis – volume: 29 start-page: 457 year: 2016 end-page: 466 ident: bib26 article-title: Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions publication-title: Protein Eng. Des. Sel. contributor: fullname: Mössner – volume: 35 year: 2021 ident: bib14 article-title: Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1 publication-title: FASEB J. contributor: fullname: Rutkowski – volume: 37 start-page: E9 year: 2014 ident: bib56 article-title: Bevacizumab for glioblastoma: current indications, surgical implications, and future directions publication-title: Neurosurg. Focus contributor: fullname: Aghi – volume: 14 start-page: 2340 year: 2017 end-page: 2349 ident: bib45 article-title: Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease publication-title: Mol. Pharm. contributor: fullname: Sumbria – volume: 5 start-page: 183ra57 year: 2013 end-page: 1-12 ident: bib13 article-title: Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier publication-title: Sci. Transl. Med. contributor: fullname: Luk – volume: 20 start-page: 1557 year: 2000 end-page: 1562 ident: bib39 article-title: Expression of large amino acid transporter LAT1 in rat brain endothelium publication-title: J. Cerebr. Blood Flow Metabol. contributor: fullname: Drewes – volume: 10 start-page: 6854 year: 2020 end-page: 6874 ident: bib66 article-title: Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease publication-title: Theranostics contributor: fullname: Lu – volume: 9 year: 2014 ident: bib68 article-title: TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats publication-title: PLoS One contributor: fullname: Han – volume: 6 start-page: 344 year: 2009 end-page: 351 ident: bib59 article-title: Convection-enhanced delivery in the treatment of epilepsy publication-title: Neurotherapeutics contributor: fullname: Rogawski – volume: 259 start-page: 66 year: 1991 end-page: 70 ident: bib11 article-title: Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier publication-title: J. Pharmacol. Exp. Therapeut. contributor: fullname: Friden – volume: 91 start-page: 5104 year: 1994 end-page: 5108 ident: bib70 article-title: Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Isacson – volume: 18 start-page: 447 year: 2007 end-page: 455 ident: bib44 article-title: Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation publication-title: Bioconjugate Chem. contributor: fullname: Pardridge – volume: 18 start-page: 634 year: 2012 end-page: 643 ident: bib62 article-title: Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases publication-title: Trends Mol. Med. contributor: fullname: Hayden – volume: 16 start-page: 677 year: 1998 end-page: 681 ident: bib22 article-title: An efficient route to human bispecific IgG publication-title: Nat. Biotechnol. contributor: fullname: Carter – volume: 7 start-page: 308 year: 2017 end-page: 318 ident: bib28 article-title: Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor publication-title: Theranostics contributor: fullname: Sehlin – volume: 81 start-page: 49 year: 2014 end-page: 60 ident: bib8 article-title: Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle publication-title: Neuron contributor: fullname: Tissot – volume: 691 start-page: 25 year: 1995 end-page: 36 ident: bib71 article-title: Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease publication-title: Brain Res. contributor: fullname: Bohn – volume: 37 start-page: 733 year: 1995 end-page: 739 ident: bib73 article-title: Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys publication-title: Neurosurgery contributor: fullname: Hashimoto – volume: 88 start-page: 4771 year: 1991 end-page: 4775 ident: bib10 article-title: Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Starzyk – volume: 8 start-page: 288 year: 2016 end-page: 305 ident: bib81 article-title: VH-VL orientation prediction for antibody humanization candidate selection: A case study publication-title: mAbs contributor: fullname: Georges – volume: 12 year: 2020 ident: bib20 article-title: Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys publication-title: Sci. Transl. Med. contributor: fullname: Henne – volume: 19 start-page: 1283 year: 2022 end-page: 1297 ident: bib75 article-title: Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase publication-title: Neurotherapeutics contributor: fullname: Ye – volume: 9 start-page: 617 year: 1996 end-page: 621 ident: bib23 article-title: 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization publication-title: Protein Eng. contributor: fullname: Carter – volume: 293 start-page: 1215 year: 1975 end-page: 1220 ident: bib58 article-title: Aminoglycoside therapy of gram-negative bacillary meningitis publication-title: N. Engl. J. Med. contributor: fullname: McGee – volume: 648 start-page: 348 year: 1992 end-page: 350 ident: bib72 article-title: Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity publication-title: Ann. N. Y. Acad. Sci. contributor: fullname: Lindsay – volume: 42 start-page: 385 year: 2019 end-page: 406 ident: bib60 article-title: Antisense Oligonucleotide Therapies for Neurodegenerative Diseases publication-title: Annu. Rev. Neurosci. contributor: fullname: Cleveland – volume: 34 start-page: 11577 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib87 article-title: Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo publication-title: FASEB J. doi: 10.1096/fj.201902515RR contributor: fullname: Kiseleva – volume: 12 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib9 article-title: Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aay1163 contributor: fullname: Ullman – volume: 43 start-page: 575 year: 2015 ident: 10.1016/j.chembiol.2023.09.008_bib54 article-title: The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-140741 contributor: fullname: Tucker – volume: 7 start-page: 308 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib28 article-title: Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor publication-title: Theranostics doi: 10.7150/thno.17155 contributor: fullname: Hultqvist – volume: 6 start-page: 344 year: 2009 ident: 10.1016/j.chembiol.2023.09.008_bib59 article-title: Convection-enhanced delivery in the treatment of epilepsy publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2009.01.017 contributor: fullname: Rogawski – volume: 102 start-page: 1251 year: 2009 ident: 10.1016/j.chembiol.2023.09.008_bib24 article-title: Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse publication-title: Biotechnol. Bioeng. doi: 10.1002/bit.22135 contributor: fullname: Boado – volume: 9 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib79 article-title: Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease publication-title: J. Clin. Med. contributor: fullname: Jin – volume: 37 start-page: 733 year: 1995 ident: 10.1016/j.chembiol.2023.09.008_bib73 article-title: Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys publication-title: Neurosurgery doi: 10.1227/00006123-199510000-00018 contributor: fullname: Tsukahara – volume: 38 start-page: 566 year: 2010 ident: 10.1016/j.chembiol.2023.09.008_bib48 article-title: Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.109.031534 contributor: fullname: Zhou – volume: 3 start-page: 860 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib18 article-title: Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis publication-title: Med. doi: 10.1016/j.medj.2022.09.007 contributor: fullname: Edavettal – volume: 15 start-page: 335 year: 1981 ident: 10.1016/j.chembiol.2023.09.008_bib32 article-title: Monoclonal antibody (M2) to glial and neuronal cell surfaces publication-title: J. Supramol. Struct. Cell. Biochem. doi: 10.1002/jsscb.1981.380150404 contributor: fullname: Lagenaur – volume: 537 start-page: 50 year: 2016 ident: 10.1016/j.chembiol.2023.09.008_bib53 article-title: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease publication-title: Nature doi: 10.1038/nature19323 contributor: fullname: Sevigny – volume: 5 start-page: 183ra57 year: 2013 ident: 10.1016/j.chembiol.2023.09.008_bib13 article-title: Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3005338 contributor: fullname: Couch – ident: 10.1016/j.chembiol.2023.09.008_bib34 – volume: 8 year: 2013 ident: 10.1016/j.chembiol.2023.09.008_bib84 article-title: Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor publication-title: PLoS One doi: 10.1371/journal.pone.0080110 contributor: fullname: Greineder – volume: 35 year: 2021 ident: 10.1016/j.chembiol.2023.09.008_bib14 article-title: Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1 publication-title: FASEB J. doi: 10.1096/fj.202001787R contributor: fullname: Stocki – volume: 110 start-page: 63 year: 1998 ident: 10.1016/j.chembiol.2023.09.008_bib82 article-title: Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody publication-title: Histochem. Cell Biol. doi: 10.1007/s004180050266 contributor: fullname: Kissel – ident: 10.1016/j.chembiol.2023.09.008_bib21 – volume: 18 start-page: 634 year: 2012 ident: 10.1016/j.chembiol.2023.09.008_bib62 article-title: Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2012.09.001 contributor: fullname: Southwell – volume: 11 start-page: 973 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib40 article-title: Transport of Amino Acids Across the Blood-Brain Barrier publication-title: Front. Physiol. doi: 10.3389/fphys.2020.00973 contributor: fullname: Zaragozá – volume: 6 start-page: 261ra154 year: 2014 ident: 10.1016/j.chembiol.2023.09.008_bib49 article-title: Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3009835 contributor: fullname: Yu – volume: 14 start-page: 1335 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib67 article-title: A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s Disease publication-title: Pharmaceutics doi: 10.3390/pharmaceutics14071335 contributor: fullname: Clarke – volume: 270 start-page: 14913 year: 1995 ident: 10.1016/j.chembiol.2023.09.008_bib38 article-title: Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.25.14913 contributor: fullname: Sánchez del Pino – volume: 59 start-page: 99 year: 1992 ident: 10.1016/j.chembiol.2023.09.008_bib69 article-title: Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1992.tb08880.x contributor: fullname: Spina – volume: 387 start-page: 408 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib35 article-title: Trial of Cinpanemab in Early Parkinson's Disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2203395 contributor: fullname: Lang – volume: 18 start-page: 447 year: 2007 ident: 10.1016/j.chembiol.2023.09.008_bib44 article-title: Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation publication-title: Bioconjugate Chem. doi: 10.1021/bc060349x contributor: fullname: Boado – volume: 6 start-page: 683 year: 2003 ident: 10.1016/j.chembiol.2023.09.008_bib6 article-title: Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain publication-title: Curr. Opin. Drug Discov. Dev contributor: fullname: Pardridge – volume: 6 year: 2016 ident: 10.1016/j.chembiol.2023.09.008_bib74 article-title: Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease publication-title: Transl. Psychiatry doi: 10.1038/tp.2016.186 contributor: fullname: Jiao – volume: 17 start-page: 3623 year: 1997 ident: 10.1016/j.chembiol.2023.09.008_bib77 article-title: TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.17-10-03623.1997 contributor: fullname: Alcántara – volume: 14 start-page: 2146629 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib85 article-title: Reduction of therapeutic antibody self-association using yeast-display selections and machine learning publication-title: mAbs doi: 10.1080/19420862.2022.2146629 contributor: fullname: Makowski – volume: 2 year: 2021 ident: 10.1016/j.chembiol.2023.09.008_bib89 article-title: Optimized immunofluorescence staining protocol for imaging germinal centers in secondary lymphoid tissues of vaccinated mice publication-title: STAR Protoc. doi: 10.1016/j.xpro.2021.100499 contributor: fullname: Fra-Bido – volume: 11 start-page: 593 year: 2019 ident: 10.1016/j.chembiol.2023.09.008_bib27 article-title: A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions publication-title: mAbs doi: 10.1080/19420862.2018.1564510 contributor: fullname: Neiveyans – volume: 20 start-page: 1557 year: 2000 ident: 10.1016/j.chembiol.2023.09.008_bib39 article-title: Expression of large amino acid transporter LAT1 in rat brain endothelium publication-title: J. Cerebr. Blood Flow Metabol. doi: 10.1097/00004647-200011000-00005 contributor: fullname: Duelli – volume: 10 start-page: 49 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib50 article-title: Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody publication-title: Alzheimer's Res. Ther. doi: 10.1186/s13195-018-0377-8 contributor: fullname: Syvänen – volume: 4 start-page: 157 year: 2015 ident: 10.1016/j.chembiol.2023.09.008_bib55 article-title: Use of bevacizumab in recurrent glioblastoma publication-title: CNS Oncol. doi: 10.2217/cns.15.8 contributor: fullname: Ghiaseddin – volume: 1018 start-page: 175 year: 2013 ident: 10.1016/j.chembiol.2023.09.008_bib88 article-title: Immunofluorescence staining with frozen mouse or chick embryonic tissue sections publication-title: Methods Mol. Biol. doi: 10.1007/978-1-62703-444-9_17 contributor: fullname: Wang – volume: 13 start-page: 4 year: 2019 ident: 10.1016/j.chembiol.2023.09.008_bib78 article-title: Loss of TrkB Signaling Due to Status Epilepticus Induces a proBDNF-Dependent Cell Death publication-title: Front. Cell. Neurosci. doi: 10.3389/fncel.2019.00004 contributor: fullname: Montroull – volume: 81 start-page: 49 year: 2014 ident: 10.1016/j.chembiol.2023.09.008_bib8 article-title: Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle publication-title: Neuron doi: 10.1016/j.neuron.2013.10.061 contributor: fullname: Niewoehner – volume: 9 year: 2014 ident: 10.1016/j.chembiol.2023.09.008_bib68 article-title: TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats publication-title: PLoS One contributor: fullname: Kim – volume: 10 start-page: 6854 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib66 article-title: Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease publication-title: Theranostics doi: 10.7150/thno.44165 contributor: fullname: Wang – volume: 61 start-page: 221 year: 1985 ident: 10.1016/j.chembiol.2023.09.008_bib31 article-title: Use of a species-specific antibody for demonstrating mouse neurons transplanted to rat brains publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(85)90428-8 contributor: fullname: Lund – volume: 146 start-page: 735 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib19 article-title: Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity publication-title: J. Neurochem. doi: 10.1111/jnc.14482 contributor: fullname: Haqqani – volume: 77 start-page: 295 year: 1972 ident: 10.1016/j.chembiol.2023.09.008_bib57 article-title: Treatment of gram-negative bacillary meningitis in adults publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-77-2-295 contributor: fullname: Rahal – volume: 9 start-page: 182 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib42 article-title: The making of bispecific antibodies publication-title: mAbs doi: 10.1080/19420862.2016.1268307 contributor: fullname: Brinkmann – volume: 691 start-page: 25 year: 1995 ident: 10.1016/j.chembiol.2023.09.008_bib71 article-title: Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease publication-title: Brain Res. doi: 10.1016/0006-8993(95)00596-I contributor: fullname: Yoshimoto – volume: 22 start-page: 149 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib52 article-title: Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.12.019 contributor: fullname: Weber – volume: 10 start-page: 765 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib51 article-title: Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration publication-title: mAbs doi: 10.1080/19420862.2018.1465159 contributor: fullname: Karaoglu Hanzatian – volume: 91 start-page: 5104 year: 1994 ident: 10.1016/j.chembiol.2023.09.008_bib70 article-title: Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.91.11.5104 contributor: fullname: Frim – volume: 13 start-page: 3788 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib86 article-title: Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space publication-title: Nat. Commun. doi: 10.1038/s41467-022-31457-3 contributor: fullname: Makowski – volume: 19 start-page: 1283 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib75 article-title: Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase publication-title: Neurotherapeutics doi: 10.1007/s13311-022-01248-1 contributor: fullname: Kang – volume: 9 start-page: 617 year: 1996 ident: 10.1016/j.chembiol.2023.09.008_bib23 article-title: 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization publication-title: Protein Eng. doi: 10.1093/protein/9.7.617 contributor: fullname: Ridgway – volume: 568 start-page: 127 year: 2019 ident: 10.1016/j.chembiol.2023.09.008_bib16 article-title: Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex publication-title: Nature doi: 10.1038/s41586-019-1011-z contributor: fullname: Yan – volume: 114 start-page: 10773 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib76 article-title: TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1713969114 contributor: fullname: Kang – volume: 3 start-page: 84ra44 year: 2011 ident: 10.1016/j.chembiol.2023.09.008_bib4 article-title: Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3002230 contributor: fullname: Yu – volume: 544 start-page: 362 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib63 article-title: Antisense oligonucleotide therapy for spinocerebellar ataxia type 2 publication-title: Nature doi: 10.1038/nature22044 contributor: fullname: Scoles – volume: 387 start-page: 421 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib36 article-title: Trial of Prasinezumab in Early-Stage Parkinson's Disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2202867 contributor: fullname: Pagano – volume: 8 start-page: 288 year: 2016 ident: 10.1016/j.chembiol.2023.09.008_bib81 article-title: VH-VL orientation prediction for antibody humanization candidate selection: A case study publication-title: mAbs doi: 10.1080/19420862.2015.1117720 contributor: fullname: Bujotzek – volume: 26 start-page: 1366 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib46 article-title: A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.02.032 contributor: fullname: Sonoda – volume: 42 start-page: 385 year: 2019 ident: 10.1016/j.chembiol.2023.09.008_bib60 article-title: Antisense Oligonucleotide Therapies for Neurodegenerative Diseases publication-title: Annu. Rev. Neurosci. doi: 10.1146/annurev-neuro-070918-050501 contributor: fullname: Bennett – volume: 54 start-page: 1882 year: 1990 ident: 10.1016/j.chembiol.2023.09.008_bib30 article-title: Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1990.tb04886.x contributor: fullname: Triguero – volume: 19 start-page: 58 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib43 article-title: Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2020.08.014 contributor: fullname: Do – volume: 178 year: 2021 ident: 10.1016/j.chembiol.2023.09.008_bib61 article-title: Nucleic acid delivery for therapeutic applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2021.113834 contributor: fullname: Gupta – volume: 292 start-page: 3900 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib25 article-title: Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.M116.767749 contributor: fullname: Lo – volume: 89 start-page: 70 year: 2016 ident: 10.1016/j.chembiol.2023.09.008_bib17 article-title: Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies publication-title: Neuron doi: 10.1016/j.neuron.2015.11.024 contributor: fullname: Zuchero – volume: 91 start-page: 5705 year: 1994 ident: 10.1016/j.chembiol.2023.09.008_bib3 article-title: Macromolecular permeability across the blood-nerve and blood-brain barriers publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.91.12.5705 contributor: fullname: Poduslo – volume: 16 start-page: 677 year: 1998 ident: 10.1016/j.chembiol.2023.09.008_bib22 article-title: An efficient route to human bispecific IgG publication-title: Nat. Biotechnol. doi: 10.1038/nbt0798-677 contributor: fullname: Merchant – volume: 293 start-page: 1215 year: 1975 ident: 10.1016/j.chembiol.2023.09.008_bib58 article-title: Aminoglycoside therapy of gram-negative bacillary meningitis publication-title: N. Engl. J. Med. doi: 10.1056/NEJM197512112932401 contributor: fullname: Kaiser – volume: 1 start-page: 124 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib80 article-title: Anti-apoptotic effects of BDNF-TrkB signaling in the treatment of hemorrhagic stroke publication-title: Brain Hemorrhages doi: 10.1016/j.hest.2020.04.003 contributor: fullname: Hasegawa – volume: 14 start-page: 2340 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib45 article-title: Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.7b00200 contributor: fullname: Chang – volume: 88 start-page: 4771 year: 1991 ident: 10.1016/j.chembiol.2023.09.008_bib10 article-title: Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.88.11.4771 contributor: fullname: Friden – volume: 15 start-page: 1420 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib29 article-title: Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26 publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.7b00937 contributor: fullname: Thom – volume: 26 start-page: 510 year: 2019 ident: 10.1016/j.chembiol.2023.09.008_bib15 article-title: Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/s41594-019-0237-7 contributor: fullname: Lee – volume: 29 start-page: 457 year: 2016 ident: 10.1016/j.chembiol.2023.09.008_bib26 article-title: Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions publication-title: Protein Eng. Des. Sel. doi: 10.1093/protein/gzw040 contributor: fullname: Schlothauer – volume: 259 start-page: 66 year: 1991 ident: 10.1016/j.chembiol.2023.09.008_bib11 article-title: Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo publication-title: J. Pharmacol. Exp. Therapeut. contributor: fullname: Pardridge – volume: 387 start-page: 466 year: 2022 ident: 10.1016/j.chembiol.2023.09.008_bib37 article-title: Monoclonal Antibody Therapy in Parkinson's Disease - The End? publication-title: N. Engl. J. Med. doi: 10.1056/NEJMe2207681 contributor: fullname: Whone – volume: 9 start-page: S3 year: 2009 ident: 10.1016/j.chembiol.2023.09.008_bib2 article-title: Characteristics of compounds that cross the blood-brain barrier publication-title: BMC Neurol. doi: 10.1186/1471-2377-9-S1-S3 contributor: fullname: Banks – volume: 7 start-page: a020412 year: 2015 ident: 10.1016/j.chembiol.2023.09.008_bib1 article-title: The blood-brain barrier publication-title: Cold Spring Harbor Perspect. Biol. doi: 10.1101/cshperspect.a020412 contributor: fullname: Daneman – volume: 70 start-page: 883 year: 1998 ident: 10.1016/j.chembiol.2023.09.008_bib41 article-title: Examination of blood-brain barrier transferrin receptor by confocal fluorescent microscopy of unfixed isolated rat brain capillaries publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1998.70020883.x contributor: fullname: Huwyler – volume: 158 start-page: 660 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib47 article-title: Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-Transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity publication-title: Pain doi: 10.1097/j.pain.0000000000000810 contributor: fullname: Webster – volume: 16 year: 2021 ident: 10.1016/j.chembiol.2023.09.008_bib33 article-title: A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain publication-title: PLoS One doi: 10.1371/journal.pone.0252558 contributor: fullname: Pornnoppadol – volume: 94 start-page: 1056 year: 2017 ident: 10.1016/j.chembiol.2023.09.008_bib65 article-title: Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases publication-title: Neuron doi: 10.1016/j.neuron.2017.04.010 contributor: fullname: Schoch – volume: 292 start-page: 1048 year: 2000 ident: 10.1016/j.chembiol.2023.09.008_bib12 article-title: Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse publication-title: J. Pharmacol. Exp. Therapeut. contributor: fullname: Lee – volume: 12 year: 2020 ident: 10.1016/j.chembiol.2023.09.008_bib20 article-title: Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aay1359 contributor: fullname: Kariolis – volume: 648 start-page: 348 year: 1992 ident: 10.1016/j.chembiol.2023.09.008_bib72 article-title: Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1992.tb24578.x contributor: fullname: Spina – volume: 14 start-page: 9 year: 2018 ident: 10.1016/j.chembiol.2023.09.008_bib64 article-title: Antisense oligonucleotides: the next frontier for treatment of neurological disorders publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2017.148 contributor: fullname: Rinaldi – volume: 26 start-page: 9394 year: 2006 ident: 10.1016/j.chembiol.2023.09.008_bib83 article-title: Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1118-06.2006 contributor: fullname: Qian – volume: 211 start-page: 233 year: 2014 ident: 10.1016/j.chembiol.2023.09.008_bib7 article-title: Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants publication-title: J. Exp. Med. doi: 10.1084/jem.20131660 contributor: fullname: Bien-Ly – volume: 12 start-page: 54 year: 2007 ident: 10.1016/j.chembiol.2023.09.008_bib5 article-title: Blood-brain barrier delivery publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2006.10.013 contributor: fullname: Pardridge – volume: 37 start-page: E9 year: 2014 ident: 10.1016/j.chembiol.2023.09.008_bib56 article-title: Bevacizumab for glioblastoma: current indications, surgical implications, and future directions publication-title: Neurosurg. Focus doi: 10.3171/2014.9.FOCUS14516 contributor: fullname: Castro |
| SSID | ssj0001637137 |
| Score | 2.5251334 |
| Snippet | The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to their use in diverse applications. One promising strategy is to... |
| SourceID | crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 361 |
| SubjectTerms | 4F2 astrocyte BBB BDNF blood-brain barrier neuron neurotrophin SLC3A2 transferrin receptor TrkB |
| Title | Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs |
| URI | https://dx.doi.org/10.1016/j.chembiol.2023.09.008 https://www.ncbi.nlm.nih.gov/pubmed/37890480 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6FcuGCgPIoFLQHxMWysb1rJz6WAi0VqZBopYqLZe-jcVXsqHEO6b_gHzOz67V9iFQeFyvZyPZq5svszOw3s4S8jbFnVygzP5UaAhSmhF-IiPlFHKki0QWEDLijOz9Nj8_5yUVyMZn8GrGW1m0ZiNutdSX_olUYA71ilexfaLZ_KAzAZ9AvXEHDcP0jHX-osFASyT4eCKgqG7nxVos1tiVeeZbjbbb1P2azhbBFIq2hcFSmDNJsHFw39aV_DTYPPFE8LsKTCr_Znfcvl0ersft6iJk-4XoMdA2ceuva3NR1s1xikyiTbl8UIJKq59W4E4y_FhvwbI-CnguE566NKPzeSf_Tj_US-4GIMQ_HmwfjVEXMkd1sizVt_szV0AyEJTBzMU8iP-O2vbizyd3KUI1CY2tgmW3d3q3VbBoHarZ1JbBJiasAZYLiCPCceNPSNpwNa1_PSPyO08BZQEgWsnia3iP3Y7BdqbH1yZC2S9nUdmLt5z2qO9_-ujtcnpE_c_aIPOwCEXpgUfWYTFT9hOwe1EXb_NzQd9RQg41-d4kagEYd0KgDGu2BRi3QaAc02gMNbpJ0ABo1QKMOaLTRFIH2lJx__nR2eOx353P4gqWz1o-kVhCbwQKZpEzwaci1jMpUchgPdcw0ExrC2aiAAcFlqrgOpeJpqDOdCVjYnpGduqnVC0Kl1OArFmAYdMnBpy0zhQcsSg0eFuNJtkfeOxHmS9uGJXf8xKvcCT1HoedhloPQ90jmJJ13zqR1EnNAyJ33Preq6d_FsF6cz8KX__HUV-TB8KfYJzvtzVq9Bo-2Ld8YjMH19Nv8N6YcpNE |
| link.rule.ids | 315,783,787,27936,27937 |
| linkProvider | ABC ChemistRy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bispecific+antibody+shuttles+targeting+CD98hc+mediate+efficient+and+long-lived+brain+delivery+of+IgGs&rft.jtitle=Cell+chemical+biology&rft.au=Pornnoppadol%2C+Ghasidit&rft.au=Bond%2C+Layne+G.&rft.au=Lucas%2C+Michael+J.&rft.au=Zupancic%2C+Jennifer+M.&rft.date=2024-02-15&rft.pub=Elsevier+Ltd&rft.issn=2451-9456&rft.volume=31&rft.issue=2&rft.spage=361&rft.epage=372.e8&rft_id=info:doi/10.1016%2Fj.chembiol.2023.09.008&rft.externalDocID=S2451945623003276 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2451-9456&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2451-9456&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2451-9456&client=summon |